Guardant Health, Inc. Earnings

Guardant Health, Inc.’s revenue jumped 33.87% since last year same period to $191.48Mn in the Q3 2024. On a quarterly growth basis, Guardant Health, Inc. has generated 8.04% jump in its revenue since last 3-months.

Guardant Health, Inc.’s net profit fell -25.15% since last year same period to $-107.75Mn in the Q3 2024. On a quarterly growth basis, Guardant Health, Inc. has generated -4.99% fall in its net profits since last 3-months.

Guardant Health, Inc.’s net profit margin jumped 6.52% since last year same period to -56.28% in the Q3 2024. On a quarterly growth basis, Guardant Health, Inc. has generated 2.81% jump in its net profit margins since last 3-months.

Guardant Health, Inc.’s earning per share (EPS) estimates for the current year stand at -0.85.

Guardant Health, Inc.’s earning per share (EPS) fell -20.55% since last year same period to -0.88 in the Q3 2024. This indicates that the Guardant Health, Inc. has generated -20.55% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Guardant Health, Inc.’s return on assets (ROA) stands at -0.16.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Guardant Health, Inc.’s return on equity (ROE) stands at -6.09.